Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
fibrosis10255 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A27348 | 18596193 | Gut | Effectiveness of antiplatelet drugs against experimental non-alcoholic fatty liver disease. | 2008 | Details |
| A27349 | 18595129 | World J Gastroenterol | Is there a place for serum laminin determination in patients with liver disease and cancer? | 2008 | Details |
| A27353 | 21479447 | Mol Med Rep | Neovascularization and oxidative stress in the progression of non-alcoholic steatohepatitis. | 2012 | Details |
| A27355 | 18567074 | World J Gastroenterol | Non-invasive means of measuring hepatic fat content. | 2008 | Details |
| A27357 | 18565022 | J Gastroenterol Hepatol | Genetic polymorphisms of adiponectin and tumor necrosis factor-alpha and nonalcoholic fatty liver disease in Chinese people. | 2008 | Details |
| A27363 | 18546525 | Zhejiang Da Xue Xue Bao Yi Xue Ban | [Clinical value of hepatic fibrosis parameters and serum ferritin in obese children with nonalcoholic fatty liver disease]. | 2008 | Details |
| A27371 | 18515091 | Gastroenterology | The Kruppel-like factor 6 genotype is associated with fibrosis in nonalcoholic fatty liver disease. | 2008 | Details |
| A27373 | 19669306 | Hepatol Int | Advanced hepatic fibrosis and cirrhosis due to nonalcoholic fatty liver disease in Sri Lankan children: a preliminary report. | 2008 | Details |
| A27375 | 19669303 | Hepatol Int | Nonalcoholic fatty liver disease in a district general hospital: clinical presentation and risk factors. | 2008 | Details |
| A27378 | 18510618 | Am J Gastroenterol | Increased hepatic and circulating interleukin-6 levels in human nonalcoholic steatohepatitis. | 2008 | Details |
| A27384 | 18501344 | Eur J Pharmacol | Olmesartan ameliorates a dietary rat model of non-alcoholic steatohepatitis through its pleiotropic effects. | 2008 | Details |
| A27391 | 18486983 | J Hepatol | Angiotensin II-induced non-alcoholic fatty liver disease is mediated by oxidative stress in transgenic TG(mRen2)27(Ren2) rats. | 2008 | Details |
| A27393 | 18486560 | Clin Gastroenterol Hepatol | Nonalcoholic fatty liver disease in children: a single center experience. | 2008 | Details |
| A27394 | 18484615 | Anat Rec (Hoboken) | Hepatic microcirculation in fatty liver disease. | 2008 | Details |
| A27395 | 18484349 | Ann Med | Association of liver disease with postprandial large intestinal triglyceride-rich lipoprotein accumulation and pro/antioxidant imbalance in normolipidemic non-alcoholic steatohepatitis. | 2008 | Details |
| A27398 | 18471547 | Gastroenterology | Diagnosis and therapy of nonalcoholic steatohepatitis. | 2008 | Details |
| A27404 | 18426499 | J Neuroendocrinol | The endocannabinoid system and liver diseases. | 2008 | Details |
| A27410 | 18445359 | Curr Diab Rep | Genes and nonalcoholic fatty liver disease. | 2008 | Details |
| A27415 | 18430557 | J Nutr Biochem | The role of fatty acids in the development and progression of nonalcoholic fatty liver disease. | 2008 | Details |
| A27416 | 18422963 | J Gastroenterol Hepatol | Polaprezinc attenuates liver fibrosis in a mouse model of non-alcoholic steatohepatitis. | 2008 | Details |
| A27421 | 18417155 | Life Sci | The establishment of a novel non-alcoholic steatohepatitis model accompanied with obesity and insulin resistance in mice. | 2008 | Details |
| A27426 | 18403941 | Eur J Gastroenterol Hepatol | Risk factors associated with nonalcoholic fatty liver disease and its relationship with the hepatic histological changes. | 2008 | Details |
| A27436 | 18390575 | Gut | Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease. | 2008 | Details |
| A27448 | 18370830 | Metab Syndr Relat Disord | Nonalcoholic steatohepatitis and the metabolic syndrome. | 2008 | Details |
| A27453 | 18367854 | Korean J Hepatol | [Nonalcoholic steatohepatitis: pathogenesis and treatment]. | 2008 | Details |
| A27460 | 18346131 | Liver Int | Macaca radiata (bonnet monkey): a spontaneous model of nonalcoholic fatty liver disease. | 2008 | Details |
| A27463 | 18335793 | Natl Med J India | Spectrum of histological features in non-alcoholic fatty liver disease. | 2008 | Details |
| A27466 | 18333122 | HPB (Oxford) | Hepato-pancreato-biliary fat: the good, the bad and the ugly. | 2007 | Details |
| A27470 | 18329014 | Eur J Pharmacol | Ezetimibe improves high fat and cholesterol diet-induced non-alcoholic fatty liver disease in mice. | 2008 | Details |
| A27472 | 18324772 | J Agric Food Chem | Dietary phosphatidylinositol prevents the development of nonalcoholic fatty liver disease in Zucker (fa/fa) rats. | 2008 | Details |
| A27473 | 18321606 | J Hepatol | Relationship of steatosis grade and zonal location to histological features of steatohepatitis in adult patients with non-alcoholic fatty liver disease. | 2008 | Details |
| A27474 | 18321154 | Expert Opin Emerg Drugs | Emerging drugs for non-alcoholic fatty liver disease. | 2008 | Details |
| A27486 | 18299981 | Dig Dis Sci | The transition from fatty liver to NASH associates with SAMe depletion in db/db mice fed a methionine choline-deficient diet. | 2008 | Details |
| A27487 | 18299664 | Minerva Gastroenterol Dietol | The clinical aspects of non-alcoholic fatty liver disease. | 2008 | Details |
| A27489 | 18296738 | Exp Biol Med (Maywood) | Evidence-based efficacy of Kampo formulas in a model of non alcoholic fatty liver. | 2008 | Details |
| A27491 | 18289064 | Curr Pharm Des | Models for non-alcoholic fatty liver disease: a link with vascular risk. | 2008 | Details |
| A27492 | 18286348 | Obes Surg | High prevalence of small intestinal bacterial overgrowth in patients with morbid obesity: a contributor to severe hepatic steatosis. | 2008 | Details |
| A27493 | 18277896 | J Clin Gastroenterol | The 13C-caffeine breath test detects significant fibrosis in patients with nonalcoholic steatohepatitis. | 2008 | Details |
| A27498 | 18266250 | Hepatology | Health-related fitness and physical activity in patients with nonalcoholic fatty liver disease. | 2008 | Details |
| A27500 | 18261709 | Dig Liver Dis | A pilot trial of fenofibrate for the treatment of non-alcoholic fatty liver disease. | 2008 | Details |
| A27501 | 18254260 | Acta Gastroenterol Latinoam | [Nonalcoholic fatty liver disease: clinical and histological characteristics in obese who underwent bariatric surgery]. | 2007 | Details |
| A27504 | 18249301 | Eur J Intern Med | Evolving trends in nonalcoholic fatty liver disease. | 2008 | Details |
| A27509 | 18239590 | Obesity (Silver Spring) | ACE inhibition and AT1 receptor blockade prevent fatty liver and fibrosis in obese Zucker rats. | 2007 | Details |
| A27510 | 18221603 | Curr Treat Options Gastroenterol | Current treatments in nonalcoholic steatohepatitis. | 2007 | Details |
| A27511 | 18220286 | Hepatology | Low circulating levels of dehydroepiandrosterone in histologically advanced nonalcoholic fatty liver disease. | 2008 | Details |
| A27515 | 18218674 | Gut | Waist circumference correlates with liver fibrosis in children with non-alcoholic steatohepatitis. | 2008 | Details |
| A27516 | 18218340 | Trends Mol Med | Molecular basis and mechanisms of progression of non-alcoholic steatohepatitis. | 2008 | Details |
| A27518 | 18214632 | Obes Surg | The utility of the "NAFLD fibrosis score" in morbidly obese subjects with NAFLD. | 2008 | Details |
| A27525 | 18186554 | World J Gastroenterol | Nonalcoholic fatty liver disease and mitochondrial dysfunction. | 2008 | Details |
| A27530 | 18177455 | Am J Gastroenterol | Cytokines in the pathogenesis of fatty liver and disease progression to steatohepatitis: implications for treatment. | 2008 | Details |
| A27533 | 18081662 | Aliment Pharmacol Ther | Review article: Non-alcoholic fatty liver disease in morbidly obese patients and the effect of bariatric surgery. | 2007 | Details |
| A27538 | 18163194 | Obes Surg | Correlations of laparoscopy with histology and laboratory studies on liver diseases in bariatric patients. | 2007 | Details |
| A27545 | 18090161 | J Clin Gastroenterol | Liver enzymes and histology in obese patients with obstructive sleep apnea. | 2008 | Details |
| A27547 | 18087267 | Int J Obes (Lond) | Metabolic syndrome and liver histology in paediatric non-alcoholic steatohepatitis. | 2007 | Details |
| A27550 | 18083083 | Dig Liver Dis | Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with nonalcoholic fatty liver disease (NAFLD). | 2007 | Details |
| A27551 | 18081738 | Aliment Pharmacol Ther | Adipokines and cytokines in non-alcoholic fatty liver disease. | 2007 | Details |
| A27554 | 18075282 | J Endocrinol Invest | Plasminogen activator inhibitor-1 and thrombin activatable fibrinolysis inhibitor levels in non-alcoholic steatohepatitis. | 2007 | Details |
| A27556 | 18074737 | Acta Gastroenterol Belg | Clinical, biochemical and histological correlations in a group of non-drinker subjects with non-alcoholic fatty liver disease. | 2008 | Details |
| A27560 | 18066656 | Inflammation | The treatment with antibody of TNF-alpha reduces the inflammation, necrosis and fibrosis in the non-alcoholic steatohepatitis induced by methionine- and choline-deficient diet. | 2007 | Details |
| A27561 | 18062158 | Praxis (Bern 1994) | [Non-alcoholic steatohepatitis--a new epidemic]. | 2007 | Details |
| A27569 | 18042105 | Am J Gastroenterol | Abdominal ultrasound for diagnosis of nonalcoholic fatty liver disease (NAFLD). | 2007 | Details |
| A27570 | 18038452 | Hepatology | Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: Validating the European Liver Fibrosis Panel and exploring simple markers. | 2008 | Details |
| A27571 | 18035683 | Verh Dtsch Ges Pathol | [Alcoholic and non-alcoholic steatohepatitis]. | 2005 | Details |
| A27573 | 18030620 | Dig Dis Sci | Independent predictors of steatohepatitis and fibrosis in Asian Indian patients with non-alcoholic steatohepatitis. | 2007 | Details |
| A27574 | 18025069 | Gut | Serum apoptotic caspase activity as a marker of severity in HBeAg-negative chronic hepatitis B virus infection. | 2007 | Details |
| A27575 | 18022391 | FEBS Lett | Ezetimibe improves liver steatosis and insulin resistance in obese rat model of metabolic syndrome. | 2007 | Details |
| A27576 | 18019712 | Hepatogastroenterology | Body mass index in Japanese patients with autoimmune liver disease: overweight patients with primary biliary cirrhosis tend to be asymptomatic. | 2007 | Details |
| A27578 | 18007556 | Ann Hepatol | Changes in histological criteria lead to different prevalences of nonalcoholic steatohepatitis in severe obesity. | 2008 | Details |
| A27580 | 18007551 | Ann Hepatol | Metformin is effective in achieving biochemical response in patients with nonalcoholic fatty liver disease (NAFLD) not responding to lifestyle interventions. | 2008 | Details |
| A27589 | 17976158 | Liver Int | Clinicopathological study of nonalcoholic fatty liver disease in Japan: the risk factors for fibrosis. | 2007 | Details |
| A27590 | 17975129 | Am J Physiol Gastrointest Liver Physiol | Endocannabinoids and liver disease. I. Endocannabinoids and their receptors in the liver. | 2007 | Details |
| A27593 | 17964913 | Med Clin North Am | Nonalcoholic fatty liver disease as a complication of insulin resistance. | 2007 | Details |
| A27600 | 17937811 | BMC Gastroenterol | Meta-analyses of FibroTest diagnostic value in chronic liver disease. | 2007 | Details |
| A27602 | 17932230 | Am J Physiol Gastrointest Liver Physiol | The proinflammatory phenotype of PECAM-1-deficient mice results in atherogenic diet-induced steatohepatitis. | 2007 | Details |
| A27604 | 17919226 | Liver Int | Treating nonalcoholic fatty liver disease. | 2007 | Details |
| A27607 | 17916170 | Intern Med J | The HFE gene heterozygosis H63D: a cofactor for liver damage in patients with steatohepatitis? Epidemiological and clinical considerations. | 2007 | Details |
| A27618 | 24573937 | Front Med China | Pathological study of 130 cases of nonalcoholic fatty liver disease based on NASH-CRN system. | 2007 | Details |
| A27632 | 17874726 | Vojnosanit Pregl | [Non-alcoholic fatty liver disease in obese persons with diabetes]. | 2007 | Details |
| A27633 | 17872748 | Can Fam Physician | Managing nonalcoholic fatty liver disease: recommendations for family physicians. | 2007 | Details |
| A27634 | 17868334 | J Gastroenterol Hepatol | Interstrain differences in susceptibility to non-alcoholic steatohepatitis. | 2007 | Details |
| A27638 | 17846888 | Dig Dis Sci | Fibrogenesis in fatty liver associated with obesity and diabetes mellitus type 2. | 2007 | Details |
| A27639 | 17845148 | Expert Opin Ther Targets | Present and future therapeutic strategies in non-alcoholic fatty liver disease. | 2007 | Details |
| A27642 | 17786144 | Ann Hepatol | Angiogenesis in chronic liver disease. | 2007 | Details |
| A27645 | 17767466 | Aliment Pharmacol Ther | Histological progression of non-alcoholic fatty liver disease: a critical reassessment based on liver sampling variability. | 2007 | Details |
| A27649 | 17764530 | J Gastroenterol Hepatol | Reduction of fibrosis in a rat model of non-alcoholic steatohepatitis cirrhosis by human HGF gene transfection using electroporation. | 2007 | Details |
| A27650 | 17761893 | J Endocrinol | Infliximab reverses steatosis and improves insulin signal transduction in liver of rats fed a high-fat diet. | 2007 | Details |
| A27652 | 17729403 | World J Gastroenterol | Pathogenesis and management issues for non-alcoholic fatty liver disease. | 2007 | Details |
| A27656 | 17722791 | Tunis Med | [Role of mitochondrial dysfunction in non-alcoholic steatohepatitis]. | 2003 | Details |
| A27659 | 17567478 | J Gastroenterol Hepatol | Non-alcoholic steatohepatitis and hepatocellular carcinoma: lessons from hepatocyte-specific phosphatase and tensin homolog (PTEN)-deficient mice. | 2007 | Details |
| A27660 | 17567476 | J Gastroenterol Hepatol | Role of adipocytokines in hepatic fibrogenesis. | 2007 | Details |
| A27661 | 17567475 | J Gastroenterol Hepatol | Role of oxidative stress and Kupffer cells in hepatic fibrosis. | 2007 | Details |
| A27668 | 17708600 | World J Gastroenterol | Female hepatology: favorable role of estrogen in chronic liver disease with hepatitis B virus infection. | 2007 | Details |
| A27672 | 17702661 | Clin Gastroenterol Hepatol | Histopathologic variability between the right and left lobes of the liver in morbidly obese patients undergoing Roux-en-Y bypass. | 2007 | Details |
| A27674 | 17696255 | World J Gastroenterol | Common genetic variations in CLOCK transcription factor are associated with nonalcoholic fatty liver disease. | 2007 | Details |
| A27675 | 17694770 | Niger J Med | Diabetes co-existing with chronic liver disease: clinical features and response to therapy. | 2007 | Details |
| A27681 | 17683488 | J Gastroenterol Hepatol | Protein glutathionylation increases in the liver of patients with non-alcoholic fatty liver disease. | 2007 | Details |
| A27683 | 17675901 | J Cardiometab Syndr | Nonalcoholic steatohepatitis and the cardiometabolic syndrome. | 2006 | Details |
| A27688 | 17661414 | Hepatology | Noninvasive diagnosis and monitoring of nonalcoholic steatohepatitis: present and future. | 2007 | Details |
| A27691 | 17657385 | Singapore Med J | Significant non-alcoholic fatty liver disease is found in non-diabetic, pre-obese Chinese in Singapore. | 2007 | Details |
| A27697 | 17653654 | J Gastroenterol | High-sensitivity C-reactive protein is an independent clinical feature of nonalcoholic steatohepatitis (NASH) and also of the severity of fibrosis in NASH. | 2007 | Details |